NCT04704258 - NAUTILUS CE-mark Trial of the FLOWer Cerebral Embolic Protection Device | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

May 3, 2021

Primary Completion Date

June 6, 2023

Study Completion Date

June 6, 2023

Conditions

Aortic Valve StenosisIntracranial Embolism and Thrombosis

Interventions

PROCEDURE

TAVI (Transcatheter Aortic Valve Implant)

Placement of a filter to capture and remove emboli or debris detached during any transcatheter heart procedures

DEVICE

FLOWer Embolic Protection System

Trial Locations (8)

CUB Hôpital Erasme (ULB), Brussels

HartCentrum, Ziekenhuis Netwerk Antwerpen (ZNA) Middelheim, Antwerp

IRCCS Policlinico San Donato, San Donato Milanese

IRCCS Ospedale San Raffaele, Milan

Centro Cardiologico Monzino IRCCS, Milan

Casa di Cura Policlinico di Monza, Monza

Clinica San Gaudenzio, Novara

San Carlo Azienda Ospedaliera Regionale, Potenza